Fluent Financial’s Bristol-Myers Squibb BMY Stock Holding History

Fluent Financial’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-29,800	Closed	-$120K	–	53
2020 Q1	$120K	Buy	+29,800	New	+$1.82M	0.09%	53

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fluent Financial's BMY Position: Q2 2021 in Review

Fluent Financial sold out of Bristol-Myers Squibb (BMY) in Q2 2021, closing a stake of 63,638 shares — an estimated $3.95M sold.

Fluent Financial first reported a position in BMY in Q4 2019 and held it in 6 quarters. The position peaked at $5.5M in Q3 2020. 2,369 funds tracked by Wall St. Rank hold BMY as of Q2 2021.

Fluent Financial reported no remaining Bristol-Myers Squibb position as of Q2 2021 after selling out during the quarter.
Fluent Financial sold 63,638 Bristol-Myers Squibb shares in Q2 2021, an estimated $3.95M.
Fluent Financial first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 6 quarters.
Fluent Financial's Bristol-Myers Squibb position peaked at $5.5M in Q3 2020.
2,369 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2021.

Based on Fluent Financial's 13F filing for Q2 2021, filed 3 Aug 2021.